Prime Medicine, Inc.PRMENASDAQ
Loading
Year-over-year operating income growth rate
Latest
9.94%
↑ 130% vs avg
Percentile
P86
Within normal range
Streak
3 qtr
Consecutive growthAccelerating
Average
-32.60%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 9.94% |
| Q3 2025 | -1.12% |
| Q2 2025 | -1.88% |
| Q1 2025 | -18.47% |
| Q4 2024 | 18.46% |
| Q3 2024 | 2.59% |
| Q2 2024 | -15.17% |
| Q1 2024 | 28.96% |
| Q4 2023 | -32.23% |
| Q3 2023 | -13.70% |
| Q2 2023 | -13.05% |
| Q1 2023 | -3.48% |
| Q4 2022 | -22.21% |
| Q3 2022 | -20.34% |
| Q2 2022 | -32.20% |
| Q1 2022 | 66.88% |
| Q4 2021 | -476.16% |
| Q3 2021 | -30.08% |
| Q2 2021 | -34.61% |
| Q1 2021 | -129.30% |
| Q4 2020 | 0.00% |
| Q4 2019 | 0.00% |